FDA inspection
Cadila Pharmaceuticals Limited: FDA inspection ending Mar 28, 2014
FDA inspection 873262 · Official Action Indicated (OAI) · Ankleshwar
Key facts
| Inspection ID | 873262 |
|---|---|
| Firm | Cadila Pharmaceuticals Limited |
| FEI number | 3002806711 |
| Address | 294, G.I.D.C. Industrial Estate |
| City | Ankleshwar |
| Country | India |
| Fiscal year | 2014 |
| Inspection end date | Mar 28, 2014 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data